Regulation of types I and III NOS in ovine uterine arteries by daily and acute estrogen exposure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 6 47-6, 2000, Pages

  Salhab, Walid A ^a   Shaul, Philip W ^a   Cox, Blair E ^a   Rosenfeld, Charles R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Endothelium; Guanosine 3',5' cyclic monophosphate; Guanylyl cyclase; Vascular smooth muscle

Indexed keywords

CYCLIC GMP; ESTRADIOL 17BETA DEHYDROGENASE; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; SHEEP; UTERINE ARTERY; UTERUS BLOOD FLOW; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0033935574     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.6.h2134     Document Type: Article

References (46)

1. Bell DR, Rensberger HJ, Koritnik DR, and Koshy A. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am J Physiol Heart Circ Physiol 258: H377-H383, 1990.
2. Boulanger CM, Heymes C, Benessiano J, Geske RS, Levy BI, and Vanhoute PM. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res 83: 1271-1278, 1998.
3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
4. Bredt DS and Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685, 1990.
5. Ceccatelli S, Grandison L, Scott RE, Pfaff DW, and Kow LM. Estradiol regulation of nitric oxide synthase mRNAs in rat hypothalamus. Neuroendocrinology 64: 357-363, 1996.
6. Clewell WH, Stys S, and Meschia G. Stimulus summation and tachyphylaxis in estrogen response in sheep. Am J Obstet Gynecol 138: 485-493, 1980.
7. Darkow DJ, Lu L, and White RE. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP. Am J Physiol Heart Circ Physiol 272: H2765-H2773, 1997.
8. de Ziegler D, Bessis R, and Frydman R. Vascular resistance of uterine arteries: physiological effects of estradiol and progesterone. Fertil Steril 55: 775-779, 1991.
9. Forstermann U, Schmidt HHHW, Pollack JS, Sheng H, Mitchell JA, Warner TD, Nakane N, and Murad F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 42: 1849-1857, 1991.
10. Greiss, FC Jr and Anderson SG. Effect of ovarian hormones on the uterine vascular bed. Am J Obstet Gynecol 107: 829-836, 1970.
11. Jiang C, Sarrel PM, Lindsey DC, Poole-Wilson PA, and Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 104: 1033-1037, 1991.
12. Killam AP, Rosenfeld CR, Battaglia FC, Makowski EL, and Meschia G. Effects of estrogens on the uterine blood flow of oophorectomized ewes. Am J Obstet Gynecol 115: 1045-1052, 1973.
13. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, and Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol Lung Cell Mol Physiol 273: L119-L126, 1997.
14. Lubarsky SL, Sibai BM, and Ahokas RA. Evidence of a nonendothelial source of nitric oxide in the isolated perfused hindlimb vasculature of the pregnant rat. Hypertens Preg 18: 11-21, 1999.
15. MacRitchie AN, Jun SS, Chen Z, German Z, Yuhanna IS, Sherman TS, and Shaul PW. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 81: 355-362, 1997.
16. Magness RR, Parker CR Jr, and Rosenfeld CR. Systemic and uterine responses to chronic infusion of estradiol-17β. Am J Physiol Endocrinol Metab 265: E690-E698, 1993.
17. Magness RR, Phernetton TM, and Zheng J. Systemic and uterine blood flow distribution during prolonged infusion of 17β-estradiol. Am J Physiol Heart Circ Physiol 275: H731-H743, 1998.
18. Magness RR and Rosenfeld CR. Local and systemic estradiol-17β: effects on uterine and systemic vasodilation. Am J Physiol Endocrinol Metab 256: E536-E542, 1989.
19. Markee JE. Rhythmic vascular changes. Am J Physiol 100: 32-39, 1932.
20. Mendelsohn ME and Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811, 1999.
21. Moncada S and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
22. Moncada S, Palmer RMJ, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
23. Mugge A, Riedel M, Barton M, Khun M, and Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc Res 27: 1939-1942, 1993.
24. Nadal A, Rovira JM, Laribi O, Leon-Quinto T, Andreu E, Ripoll C, and Soria B. Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. FASEB J 12: 1341-1348, 1998.
25. Nelson MT and Quayle JM. Physiologic roles and properties of potassium channels in arterial smooth muscle. Am J Physiol Cell Physiol 268: C799-C822, 1995.
26. Penney LL, Frederick RJ, and Parker GW. 17 Beta-estradiol stimulation of uterine blood flow in oophorectomized rabbits with complete inhibition of uterine ribonucleic acid synthesis. Endocrinology 109: 1672-1676, 1981.
27. Penotti M, Nencioni T, Gabrielli L, Farina M, Castiglioni E, and Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am J Obstet Gynecol 169: 1226-1232, 1993.
28. Pines A, Fisman EZ, Levo Y, Averbuch M, Lidor A, Drory Y, Finkelstein A, Hetman-Peri M, Moshkowitz M, Ben-Ari E, and Ayalon D. The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow. Am J Obstet Gynecol 164: 806-812, 1991.
29. Pirhonen JP, Vuento MH, Makinen JI, and Salmi TA. Long-term effects of hormone replacement therapy on the uterus and uterine circulation. Am J Obstet Gynecol 168: 620-623, 1993.
30. Resnik R, Battaglia FC, Makowski EL, and Meschia G. The effect of actinomycin D on estrogen-induced uterine blood flow. Am J Obstet Gynecol 122: 273-277, 1975.
31. Resnik R, Killam AP, Barton MD, Battaglia FC, Makowski EL, and Meschia G. The effects of various vasoactive compounds upon the uterine vascular bed. Am J Obstet Gynecol 125: 201-206, 1976.
32. Rosenfeld CR. The Uterine Circulation. Ithaca, NY: Perinatology, 1989.
33. Rosenfeld CR, Cox BE, Roy T, and Magness RR. Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation. J Clin Invest 98: 2158-2166, 1996.
34. Rosenfeld CR, Killam AP, Battaglia FC, Makowski EL, and Meschia G. Effect of estradiol-17β on the magnitude and distribution of uterine blood flow in nonpregnant, oophorectomized ewes. Pediatr Res 7: 139-148, 1973.
35. Rosenfeld CR, White RE, Roy T, and Cox BE. Calcium-activated potassium channels and nitric oxide co-regulate estrogen-induced vasodilation. Am J Physiol Heart Circ Physiol 279: H000-H000, 2000.
36. Schwartz J, Freeman R, and Frishman W. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women. J Clin Pharmacol 35: 1-16, 1995.
37. Sherman TS, Chen Z, Yuhanna IS, Lau KS, Margraf LR, and Shaul PW. Nitric oxide synthase isoform expression in the developing lung epithelium. Am J Physiol Lung Cell Mol Physiol 276: L383-L390, 1999.
38. 2+ uptake of uterine arterial smooth muscle cells through potential sensitive channels. Biol Reprod 36: 361-368, 1987.
39. Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RW, and Harrison DG. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol Cell Physiol 269: C1371-C1378, 1995.
40. Vagnoni KE, Shaw CE, Phernetton TM, Meglin BM, Bird IM, and Magness RR. Endothelial vasodilator production by uterine and systemic arteries. III. Ovarian and estrogen effects on NO synthase. Am J Physiol Heart Circ Physiol 275: H1845-H1856, 1998.
41. Van Buren GA, Yang D, and Clark KE. Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 167: 828-833, 1992.
42. Veille J, Li P, Eisenach JC, Massman AG, and Figueroa JP. Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vitro. Am J Obstet Gynecol 174: 1043-1049, 1996.
43. Walters WAW and Lim YL. Haemodynamic changes in women taking oral contraceptives. J Obstet Gynecol Br Comm 77: 1007-1012, 1970.
44. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, and Moncada S. Induction of calcium-dependent nitric oxide syntheses by sex hormones. Proc Natl Acad Sci USA 91: 5212-5216, 1994.
45. Ca channels through a cGMP-dependent mechanism. Circ Res 77: 936-942, 1995.
46. 2+ currents in A7r5 vascular smooth muscle line. Am J Physiol Cell Physiol 266: C975-C980, 1994.